NervGen Pharma Corp. Common stock
NervGen Pharma Corp. Common stock (NASDAQ: NGEN) is trading at $1.94, about ₹186 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 3.96% today. Indian residents can buy NervGen Pharma Corp. Common stock from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$1.92
Today's high
$2.00
52 week low
$1.58
52 week high
$6.30
NGEN opened at $2.00, closed previously at $2.02, and has traded between $1.58 and $6.30 over the past 52 weeks.
About
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Key statistics
Avg. volume
830.94K
Market cap
$159.45M
P/E Ratio
-8.41
Price-to-sales ratio
0.00
Enterprise value
CA$385.88M
Free cash flow yield
-4.78%
Debt-to-equity ratio
0.00
Return on equity
-17536.81%
ROIC
-719.57%
Beta
0.73
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
CA$0.00
Earnings per share
-CA$0.61
Free cash flow
-CA$19.50M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-CA$5.65M
Revenue growth
—
How to buy NervGen Pharma Corp. Common stock from India
Indian residents can buy NervGen Pharma Corp. Common stock shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for NervGen Pharma Corp. Common stock and place an order
Find NervGen Pharma Corp. Common stock by name or by its ticker, NGEN, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. NervGen Pharma Corp. Common stock trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your NervGen Pharma Corp. Common stock position in USD and INR. NervGen Pharma Corp. Common stock pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in NervGen Pharma Corp. Common stock from India
Trading and taxes when buying NervGen Pharma Corp. Common stock from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneNervGen Pharma Corp. Common stock does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy NervGen Pharma Corp. Common stock stock?
Yes. NervGen Pharma Corp. Common stock (NGEN) has been listed on NASDAQ since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one NervGen Pharma Corp. Common stock share cost in rupees?
One NervGen Pharma Corp. Common stock share is $1.94 — about ₹186 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the NervGen Pharma Corp. Common stock price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying NervGen Pharma Corp. Common stock from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of NervGen Pharma Corp. Common stock?
Yes. One NervGen Pharma Corp. Common stock share is $1.94, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in NervGen Pharma Corp. Common stock.
How are gains on NervGen Pharma Corp. Common stock shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the NervGen Pharma Corp. Common stock price. Paasa issues a capital-gains statement for your return.
Does NervGen Pharma Corp. Common stock pay a dividend?
No. NervGen Pharma Corp. Common stock does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade NervGen Pharma Corp. Common stock from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is NervGen Pharma Corp. Common stock a United States company, and does that change how it is taxed?
NervGen Pharma Corp. Common stock trades on NASDAQ in US dollars, but the company is domiciled in Canada. NervGen Pharma Corp. Common stock trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare NervGen Pharma Corp. Common stock shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your NervGen Pharma Corp. Common stock holding, its cost and its closing value.
How do I sell NervGen Pharma Corp. Common stock and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.